Navelbine injection is a chemotherapy drug used to treat non-small cell lung cancer and breast cancer. It contains vinorelbine, a plant alkaloid. It works by inhibiting the division of cancer cells by affecting the microtubules within the cell, thus disrupting tumor growth.
Navelbine is given intravenously or in capsule form, as recommended by the doctor. The patient requires close medical supervision because this drug may cause a decrease in white blood cells, which increases the risk of infection. It may also cause nausea, constipation, and pain in the peripheral nerves. Therefore, regular blood tests should be performed and neurological symptoms monitored during treatment. It is not recommended for use during pregnancy or breastfeeding. The doctor should be informed of all other medications being taken to avoid interactions and complications.